215 related articles for article (PubMed ID: 19736487)
1. The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli.
Gashi M; Raka L; Ahmeti S; Gashi S; Dika A; Gashi G
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):846-7. PubMed ID: 19736487
[No Abstract] [Full Text] [Related]
2. [Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China].
Wang L; Yang YH; Lu Q; Wang Y; Chen Y; Deng L; Deng QL; Zhang H; Wang CQ; Liu L; Xu XW; Shen XZ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1372-5. PubMed ID: 18953872
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
[No Abstract] [Full Text] [Related]
4. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
Paterson DL; Singh N; Gayowski T; Marino IR
Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
[No Abstract] [Full Text] [Related]
5. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
7. Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia.
Chiu SK; Chang FY
Int J Infect Dis; 2009 May; 13(3):e85-7. PubMed ID: 18848798
[TBL] [Abstract][Full Text] [Related]
8. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Apisarnthanarak A; Bailey TC; Fraser VJ
Clin Infect Dis; 2008 Apr; 46(8):1322-3. PubMed ID: 18444877
[No Abstract] [Full Text] [Related]
9. Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Krueger WA; Kempf VA; Peiffer M; Nagele U; Unertl KE; Schroeder TH
J Clin Microbiol; 2008 Feb; 46(2):817-20. PubMed ID: 18077630
[TBL] [Abstract][Full Text] [Related]
10. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
11. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
Brenwald NP; Andrews J; Fraise AP
J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
[No Abstract] [Full Text] [Related]
12. Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Berçot B; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2008 Dec; 52(12):4526-7. PubMed ID: 18838598
[No Abstract] [Full Text] [Related]
13. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
Rooney PJ; O'Leary MC; Loughrey AC; McCalmont M; Smyth B; Donaghy P; Badri M; Woodford N; Karisik E; Livermore DM
J Antimicrob Chemother; 2009 Sep; 64(3):635-41. PubMed ID: 19549667
[TBL] [Abstract][Full Text] [Related]
14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
15. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
Koh TH; Wang G; Koh TY
Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
[No Abstract] [Full Text] [Related]
16. [Resistant mutant prevention concentration of fluoroquinolones in clinical isolates of extended spectrum beta-lactamase (ESBL) producing and non-producing strains of Escherichia coli].
Noguera O; Rodríguez JC; López JM; Ruiz M; Royo G
Rev Esp Quimioter; 2009 Mar; 22(1):30-3. PubMed ID: 19308744
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum beta-lactamase-producing Escherichia coli.
Si H; Hu J; Liu Z; Zeng ZL
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):190-4. PubMed ID: 18435748
[TBL] [Abstract][Full Text] [Related]
18. Detection of drug-resistant Escherichia coli in patients with complicated cystitis: analysis of risk factors.
Shigehara K; Uchibayashi T; Maeda E; Namiki M
Int J Urol; 2009 Oct; 16(10):808-12. PubMed ID: 19659550
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
20. Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli.
Nakwan N; Nakwan N; Wannaro J; Dissaneevate P; Kritsaneepaiboon S; Chokephaibulkit K
Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):148-51. PubMed ID: 21323177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
